Company Filing History:
Years Active: 1990
Title: The Innovations of Robert A. Zivin
Introduction
Robert A. Zivin is a notable inventor based in Blue Bell, PA (US). He has made significant contributions to the field of biotechnology, particularly in the area of cardiac research. His work has led to advancements that may improve our understanding of heart-related conditions.
Latest Patents
Zivin holds a patent for "Cardiac atrial peptides." This patent involves a DNA fragment encoding at least part of the ANF protein, which has been molecularly cloned, and its nucleotide sequence has been partially determined. The composition and sequence of a peptide containing 116 amino acids within the ANF gene have been identified. Additionally, biologically active subunit peptides have been recognized, showcasing the potential for therapeutic applications.
Career Highlights
Zivin is associated with Merck & Co., Inc., a leading global healthcare company. His work at Merck has allowed him to engage in cutting-edge research and development, contributing to the advancement of medical science.
Collaborations
One of his notable collaborators is Edward M. Scolnick, who has also made significant contributions to the field of biomedical research. Their partnership exemplifies the collaborative nature of scientific innovation.
Conclusion
Robert A. Zivin's contributions to cardiac research through his patent and work at Merck & Co., Inc. highlight the importance of innovation in the medical field. His efforts continue to pave the way for future advancements in healthcare.